A multicenter trial of 6-aminocaproic acid (Amicar) in the prevention of bleeding in infants on ECMO.

Horwitz, J R; Cofer, B R; Warner, B W; Cheu, H W; Lally, K P

Horwitz, J R; Cofer, B R; Warner, B W; Cheu, H W; Lally, K P.

Affiliation

Horwitz JR; University of Texas-Houston Medical School and Hermann Children's Hospital, USA.

J Pediatr Surg ; 33(11): 1610-3, 1998 Nov.

Article in En | MEDLINE | ID: mdl-9856877

Subject(s)

Aminocaproic Acid/therapeutic use; Antifibrinolytic Agents/therapeutic use; Cerebral Hemorrhage/prevention & control; Extracorporeal Membrane Oxygenation/adverse effects; Cerebral Hemorrhage/epidemiology; Cerebral Hemorrhage/etiology; Double-Blind Method; Female; Follow-Up Studies; Humans; Infant, Newborn; Male; Prevalence; Prospective Studies; Respiratory Distress Syndrome, Newborn/therapy; Survival Rate; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Extracorporeal Membrane Oxygenation / Cerebral Hemorrhage / Aminocaproic Acid / Antifibrinolytic Agents Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Newborn Language: En Journal: J Pediatr Surg Year: 1998 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links